Comparison of Anesthesia Success Rate in Mandibular Inflammatory Tooth Between two Different Injection Techniques
- Conditions
- tooth with irreversible pulpitis.Pulpitis: NOS acute chronic (hyperplastic)(ulcerative) irreversible reversible
- Registration Number
- IRCT2013022712634N1
- Lead Sponsor
- Vice chancellor for research, Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
1) Patients with at least one posterior mandibular tooth with irreversible pulpitis for pulp therapy that each pulp therapy would be appliable thoroughly in one visit;
2) No history of taking any medication that would alter the inflammatory response of the pulp or provide analgesia for the previous 14 days;
3) No history of major systemic or cardiovascular disease;
4) Patients aged 18 to 65 years old;
5) Absence of acute inflammation and advanced periodontal disease at the injection area;
6) Provision written informed consent;
Exclusion criteria:
1) Any history of alergy to anesthetic solutions;
2) lack of cooperation or interest of patient to continue the study.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Success of the Anesthesia. Timepoint: After the Injection and during root canal therapy (RCT). Method of measurement: Vitality pulp test (pulp tester and endo ice) before RCT and questioning from patients during RCT.;Pain. Timepoint: During injection of Anesthetic solution. Method of measurement: Heft-parker visual Analogue Scale.;Blood Pressure. Timepoint: Before and After Anesthetic injection. Method of measurement: Digital indicator -mmhg.;Onset of Anesthesia. Timepoint: After the injection with 1-minute intervals for a period of 15 minutes. Method of measurement: Vitality pulp test (pulp tester and endo ice).;Duration of Anesthesia. Timepoint: From the beginning to the end of RCT. Method of measurement: Asking from the patients.
- Secondary Outcome Measures
Name Time Method Hematoma. Timepoint: One hour after the injection. Method of measurement: Observation.